JSM Biomarkers is a clinical and medical journal of international significance and widely publishes the role of biomarkers on early diagnosis, disease prevention, drug target identification, drug response for the diseases, while widely publishing the latest insights on biomarkers on open access.

Biomarkers are biomolecules that act as yardsticks or indicators for the presence of a certain pathogen or biological condition. The presence or absence of certain biomarkers signifies the onset of a certain disease or the likelihood of getting affected or eliminated from a clinical condition. The journal caters to the needs of clinical and medical PR actioners of genetics, molecular biology, biomedicine, predictive medicine, surgeons, pharmaceutical industries focused on drug design and development, academic, and diagnostic research centers, professionals and students.

JSM Biomarkers is a peer reviewed journal that encourages evidence based clinical and medical research as research articles, review articles, case reports, short communication, perspectives, commentaries, editorials, and letters to the editor.

The journal is peer reviewed and all manuscripts undergo five level thorough reviews processing of content such as plagiarism, copyediting, in-house review, independent review assignments, proofreading and typesetting to ensure scientific content quality meets the international standards.

Open Access

JSciMed Central® Open Access platform has enhanced the accessibility of scholarly published articles at your fingertips, where authors can publish their research with minimal charges and the readers can access and cite them by duly acknowledging the source. JSciMed Central® Journals strictly adhere to all the Open Access policies and all the published content is achieved forever in the repositories and universally accessible to all at free of cost. JSciMed Central® Open Access Journals deposit all it's content under Creative Common Attribution License and it allows copyrights to disseminate the work. You can read more about Open Access here.

Peer Review Policy

JSciMed Central follows a double blind peer review process. Both the author and the reviewer remain anonymous to promote quality research standards. The editor assigns the manuscript for submission to the subject experts of the concerned field by personally contacting them. The reviewers closely scrutinize the document for its validity, relevance, authenticity and significance. The reviewers comments would clearly state whether or not the manuscript followed the research methods thoroughly, by abiding by all the research ethics of privacy, confidentiality, non-violation of human and animal rights, etc., Further information about Peer review details can be found here.

The editors of the Journal invite a diverse variety of research in the field and look forward to ensuring a rise in quality and visibility of your important contributions.